Rhazes AI
Category: AI in Healthcare
An AI-powered assistant for clinicians that automates administrative tasks, provides decision support, and helps to reduce burnout. Rhazes AI was founded in 2023. The company is led by Dr. Zaid Al-Fagih. Based in London, United Kingdom. Team size: 1-10. Total funding raised: Undisclosed. Latest round: Convertible Note, Undisclosed, 2023-12. Key investors include Hatcher+, Plug and Play Tech Center, AWS Startups, Minnow Venture Partners, Qatar Development Bank.
- Founded
- 2023
- Headquarters
- London, United Kingdom
- Team size
- 1-10
- Total funding
- Undisclosed
Value proposition
To reduce administrative burden, improve clinical decision-making, and ultimately enhance patient care by freeing up clinicians' time and reducing errors.
Products and solutions
Rhazes Clinician (B2C web/mobile app), Rhazes Enterprise (with EPR integration and workflow automation), AI-powered scribe for real-time consultation transcription, Diagnostic reasoning and evidence-based management plan generation tool
Unique value
The platform is designed to be 'agentic' and adaptable to low-resource environments, not requiring extensive hospital infrastructure. It's an end-to-end solution that goes beyond simple transcription to include diagnostic reasoning and management plan generation.
Target customer
Clinicians (doctors, nurses, etc.) and healthcare organizations (hospitals, clinics).
Industries served
Healthcare
Technology advantage
The ability to deploy in challenging and low-resource settings, such as conflict zones, demonstrates the platform's robustness and adaptability. The end-to-end nature of the assistant, from scribe to decision support, provides a comprehensive solution for clinicians.
How they differentiate
Rhazes AI differentiates itself by focusing on providing an AI assistant for clinicians that is adaptable to diverse and challenging healthcare environments, including under-resourced and conflict-affected regions. Their emphasis is on creating a versatile, end-to-end AI workspace that can be used by any clinician, anywhere.
Main competitors
Abridge, Navina, Glass Health
Key partnerships
Pilot program in a war-torn Lebanese refugee hospital
Notable customers
Palestine Red Crescent Society
Major milestones
Public launch of the Rhazes AI platform., Deployment of AI scribes in a Lebanese refugee hospital, a first-of-its-kind pilot in a conflict zone., Secured investment from notable venture capitalists and accelerators including Hatcher+, Plug and Play Tech Center, and Qatar Development Bank.
Growth metrics
Not publicly available.
Market positioning
Rhazes AI is positioning itself as a comprehensive AI assistant for clinicians, designed to reduce administrative burdens, prevent burnout, and minimize diagnostic errors. Their market position is strengthened by their focus on usability and accessibility in a wide range of healthcare settings, not just traditional hospital environments.
Geographic focus
The company is headquartered in London, United Kingdom, with a notable pilot program in a refugee hospital in Lebanon. This, along with its UK-Qatar startup status, suggests an initial focus on the UK, Europe, and the Middle East, with a particular interest in humanitarian and challenging healthcare settings.
Patents and IP
Information on patents or IP is not publicly available.
About Dr. Zaid Al-Fagih
Medical doctor (MBBS, Imperial College London), worked in NHS, volunteered as aid worker in Syrian war zones, holds MPP from University of Oxford, BSc in Management from Imperial College London, previous health tech founder, NHS Clinical Entrepreneur, cross-disciplinary researcher on technology in healthcare.
More AI in Healthcare companies
Official website: https://www.rhazes.ai